stockrowOmada Health, Inc. (OMDA) vs SOPHiA GENETICS SA (SOPH)
- Omada Health, Inc. OMDA 15.10 −20.32%
- SOPHiA GENETICS SA SOPH 7.09 +7.10%
Omada Health, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. Omada Health, Inc. is the larger, with a market value of $1.2B against $563.6M — 2.1× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; Omada Health, Inc. trades at 267×. Omada Health, Inc. grew revenue faster over the last twelve months: 52.5% against 24.1%. Omada Health, Inc. has the higher net margin (1.39% vs −89.2%) and the higher return on invested capital (−0.93% vs −200.9%). Across the 17 metrics below, Omada Health, Inc. leads on 16 and SOPHiA GENETICS SA on 1.
Valuation
Profitability
| Metric | OMDA | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 68.19% | 66.43% | 59.61% |
| Operating margin | (0.15%) | (80.99%) | (10.54%) |
| Net margin | 1.39% | (89.18%) | (16.14%) |
| Free cash flow margin | 5.53% | (45.64%) | 0.00% |
| Return on equity | 1.84% | (125.67%) | (3.15%) |
| Return on assets | 1.36% | (46.60%) | (5.62%) |
| Return on invested capital | (0.93%) | (200.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack